FDA Inspection 1203534 — Fenwal International, Inc.

Fenwal International, Inc. — FEI 3002806457

The FDA completed an inspection of Fenwal International, Inc. on Apr 25, 2023 in Bajos De Haina. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 25, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bajos De Haina (Dominican Republic (the))

Citations

IDCFRDescription
311121 CFR 820.70(f)Buildings
311321 CFR 820.70(g)Equipment design and installation
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
312821 CFR 820.90(a)Nonconforming product control
313021 CFR 820.100(a)Lack of or inadequate procedures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.